Eleni Bekiari Selected Research

4,4-difluororetinoic acid

1/2013

Safety and efficacy of 4 years of deferasirox treatment for sickle cell disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleni Bekiari Research Topics

Disease

21	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2013
15	Body Weight (Weight, Body) 01/2022 - 08/2013
6	Stroke (Strokes) 01/2022 - 01/2020
5	Heart Failure 01/2022 - 01/2019
5	Nausea 01/2022 - 06/2017
4	Myocardial Infarction 01/2022 - 01/2020
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 12/2016
4	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 06/2016
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 12/2020
3	Vomiting 01/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 01/2019
3	Reproductive Tract Infections 01/2017 - 08/2013
3	Insulin Resistance 01/2011 - 12/2007
2	Infections 01/2021 - 09/2018
2	Pancreatitis 01/2020 - 06/2016
2	Weight Gain 01/2018 - 06/2017
2	Weight Loss (Weight Reduction) 01/2018 - 06/2017
1	Overweight 01/2022
1	Inflammation (Inflammations) 01/2021
1	Eye Diseases (Eye Disease) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Diarrhea 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Exanthema (Rash) 01/2019
1	Retinal Detachment (Retinal Detachments) 01/2019
1	Liver Diseases (Liver Disease) 09/2018
1	Chronic Hepatitis (Chronic Active Hepatitis) 09/2018
1	Ulcerative Colitis 09/2018
1	Latent Autoimmune Diabetes in Adults 12/2016
1	Hypercholesterolemia 08/2015
1	Neoplasms (Cancer) 04/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2014
1	Breast Neoplasms (Breast Cancer) 08/2013
1	Hemosiderosis 01/2013
1	Iron Overload 01/2013
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2013
1	Atherosclerosis 11/2010
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2008

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2017
8	Insulin (Novolin)FDA Link 01/2022 - 12/2007
6	SodiumIBA 04/2021 - 01/2019
6	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2021 - 08/2013
5	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2017
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2018
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 06/2017
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 07/2021 - 06/2017
5	semaglutideIBA 01/2021 - 01/2018
4	dapagliflozinIBA 01/2021 - 08/2013
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 04/2015
3	CanagliflozinIBA 01/2021 - 01/2017
3	Exenatide (Byetta)FDA Link 01/2021 - 01/2018
3	Liraglutide FDA Link 01/2021 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
2	Insulin Lispro (Humalog)FDA Link 10/2021 - 01/2018
2	empagliflozinIBA 01/2021 - 01/2020
2	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2020 - 01/2017
2	Ferritins (Ferritin)IBA 01/2013 - 12/2007
1	tirzepatideIBA 01/2022
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2022
1	InsulinsIBA 10/2021
1	omega-Chloroacetophenone (Mace)IBA 04/2021
1	Immunomodulating AgentsIBA 01/2021
1	pramlintide (Symlin)FDA Link 01/2021
1	ertugliflozinIBA 01/2021
1	dulaglutideIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2019
1	SymportersIBA 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	InterferonsIBA 09/2018
1	tofacitinibIBA 09/2018
1	insulin degludecIBA 01/2018
1	Insulin Glargine (Lantus)FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	2- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA 06/2017
1	AntigensIBA 12/2016
1	VildagliptinIBA 06/2016
1	AntibodiesIBA 08/2015
1	Proprotein Convertase 9IBA 08/2015
1	Indicators and Reagents (Reagents)IBA 04/2014
1	Sodium-Glucose Transport ProteinsIBA 08/2013
1	4,4-difluororetinoic acidIBA 01/2013
1	Deferasirox FDA Link 01/2013
1	Chelating AgentsIBA 01/2013
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2011
1	LeptinIBA 11/2010
1	Laminin (Merosin)IBA 11/2010
1	oxidized low density lipoproteinIBA 11/2010
1	Cocaine (Cocaine HCl)IBA 01/2008
1	Heroin (Diamorphine)IBA 01/2008

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2017
2	Surgical Amputation (Amputations) 01/2020 - 01/2020
1	Contraindications 09/2018
1	Remission Induction 09/2018
1	Artificial Pancreas 04/2018
1	Immunotherapy 12/2016
1	Tertiary Prevention 12/2016